Zai Lab Announces Change to Virtual Extraordinary General Meeting of Shareholders to be Held on March 28, 2022

Mar 23, 2022

Read More

Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting

Mar 20, 2022

Read More

Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer

Mar 15, 2022

Read More

Zai Lab Statement on SEC Provisional Listing Matter

Mar 10, 2022

Read More

Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021

Mar 01, 2022

Read More

Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China

Feb 17, 2022

Read More

Zai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2022

Feb 15, 2022

Read More

Zai Lab Announces Upcoming Presentation at February Investor Conference

Feb 07, 2022

Read More